They just announced they retained a PCAOB auditor. You don't spend 40-50 grand on an auditor unless the business you are wanting to conduct calls for it. The merger or acquisition that's coming has to be very good.

This also means that the CEO's cigar venture must have been successful otherwise he wouldn't have that kind of money to be able to bring the merger in. He alluded to moving into the "hottest sector" and we all know he's a smoker..... so the assumption is that it's a MAJOR acquisition because he's spending 40-50 grand to become FULLY REPORTING WITH THE SEC. and that it's in the MJ sector because it's the hottest sector.

I'm mobile so I can't post it on here. I just posted an l2 screenshot on twitter. Grab it from there. VFIN and VNDM are at $8.00 and $2000

So There is no dilution occurring. Company can't dilute when they aren't current yet.

Again, not even remotely true. Company isn't current yet so no one can convert and dilute. There are no dilutors on the offer. VFIN is no where to be seen. VNDM is no where to be seen.

There is no dilution.

Dr Rafei of our newly appointed scientific advisory board has been doing specialized research at McGill University. There is no doubt why he was sought out and why he agreed to advise the company.





The research program of Dr. Rafei is focused on the theme of T-cell development and modulation. The following sections will briefly outline his three main research axes.

Axis 1. Novel pharmacological strategies to improve T-cell reconstitution. Stem cell transplantation (SCT) is an established modality for the treatment of hematological malignancies. However, it is hampered by slow and often incomplete T-cell reconstitution, which leads to the development of a restricted pool of peripheral T cells. We have recently discovered novel functions for certain cytokines in stimulating hemato-/thymopoiesis. Thus, our main goals are to: i) decipher their mechanism of action using several SCT models and transcriptome analyses, and ii) develop ex vivo expansion strategies for cord-blood-derived hematopoietic stem cells.

Axis 2. Developing a new type of antigen-presenting cell (APC) as an alternative to dendritic cells (DCs) for vaccination. Mesenchymal stem cells (MSCs) have been often exploited in several medical applications including immunomodulation. For instance, potent conditional xenoantigen cross-presentation can be induced in MSCs following interferon-? treatment. Such effect is believed to be due to increased expression of major histocompatibility complex (MHC)I on MSCs cell surface; a process concomitant with enhanced generation of peptides fragments by the proteasomal machinery. As the modulation of proteasomal activity can enrich peptides capable of snugly fitting MHCI grooves, we are engineering MSCs endowed with the capacity of eliciting powerful T-cell activation. Not only can these cells be used for cellular vaccination against cancer and infectious diseases, but they can be exploited as well as a cellular platform for the discovery of new xenoantigen-derived immunogenic peptides for vaccination purposes.

Axis 3. The discovery of small molecules for modulating the function of T cells and dendritic cells. High-throughput screening is currently the mainstay for the identification of new pharmacological compounds. Using a newly developed in vitro murine fluorescent-based lymphocyte assay, my team has identified several hits with modulatory activities. Studies are currently ongoing to understand their pharmacological potential and molecular mechanism of action is order to exploit them in catastrophic illnesses.


https://www.mcgill.ca/microimm/people/adjuncts/rafei-moutih

I can't help but think that we hear something VERY soon.

More churning. Not a bad day at all.

From October:

http://m.marketwired.com/press-release/santo-mining-announces-500000-usd-retail-order-from-duty-free-shop-diplomatic-mission-otc-pink-sanp-2168186.htm

$500,000 purchase order. CEO was in China for several months and my assumption is that other deals were closed. Because, he's now back home. I'm assuming he has plenty of news to announce very soon! Let's go Frank!

Expecting updates any time now.

Bid is growing. 155mill on the bid.

Frank is back in the US and closed the deals in China. Why else would be back in the states otherwise. He all of a sudden pops back up on twitter and says he is back, discusses some things going on and posts about being back in the states working on deals via his twitter post.

I think we see some more updates soon. Should be good things coming.

Anyone else see that 140mill bid show up about an hour before close?

The CEI is back in the states. The only reason he'd be back in the states is because he closed on all his deals in China. Several $500k purchase orders.

Now he's in the states and he is focusing on more deals and meetings In the states. If I had to guess I'd say we COULD see some major updates very soon.

Starting to wake up.

https://globenewswire.com/news-release/2017/03/06/931788/0/en/ETST-Cannabis-Therapeutics-Inc-Announce-its-Cannabis-Cannabinoid-Based-Nutraceutical-Patent-Generic-Pharmaceutical-Drug-Timeline-Update.html

$etst going to be first to market with cannabis based breast cancer drug. Updated timeline, less than 1 year to market, Billion dollar market cap!

https://globenewswire.com/news-release/2017/03/06/931788/0/en/ETST-Cannabis-Therapeutics-Inc-Announce-its-Cannabis-Cannabinoid-Based-Nutraceutical-Patent-Generic-Pharmaceutical-Drug-Timeline-Update.html

$etst going to be first to market with cannabis based breast cancer drug. Updated timeline, less than 1 year to market, Billion dollar market cap!

https://globenewswire.com/news-release/2017/03/06/931788/0/en/ETST-Cannabis-Therapeutics-Inc-Announce-its-Cannabis-Cannabinoid-Based-Nutraceutical-Patent-Generic-Pharmaceutical-Drug-Timeline-Update.html

$etst going to be first to market with cannabis based breast cancer drug. Updated timeline, less than 1 year to market, Billion dollar market cap!

https://globenewswire.com/news-release/2017/03/06/931788/0/en/ETST-Cannabis-Therapeutics-Inc-Announce-its-Cannabis-Cannabinoid-Based-Nutraceutical-Patent-Generic-Pharmaceutical-Drug-Timeline-Update.html

$etst going to be first to market with cannabis based breast cancer drug. Updated timeline, less than 1 year to market, Billion dollar market cap!

So is that ADX.

You know I love a good pincher play :)

Level 2 starting to shape up the morning.

Looks like those big bids have shown up at those .0001x2 again.

News today explains that the Cancer drug should be to market by end of 2017! A cancer drug based off of cannabis medicine. Is this the first drug of it's time? Is EARTH SCIENCE TECH going to be first to market with a cannabis based Breast Cancer Drug?! That's going to be HUGE! Worth BILLIONS.

Company Pivoting on New Opportunities

https://twitter.com/i/moments/838565184067239936

Check out Santo Mining Corp. (@santominingotc): https://twitter.com/santominingotc?s=09



Interesting. Looks like a new twitter handle for the company.

Great week ahead.

Could be and with the rumors of Frank being back in the states and being in meetings all week he probably has a lot to announce..... the assumption is that he fulfilled those purchase orders that was announced in the PRs from a few months ago. They're for like $500k a piece and there were several of them. He did post that video of him going through customs.

I can only assume that something is about to be announced.

I for one like the potential on this one. It's got a huge following. Seeing that big 46mill bid show up after 60mill in ask slaps to wiping out the .0001s. Well, that just makes me wanna sing.

That almost make me want to sing Nickelback..... and no one even likes Nickelback.

There's nothing in the filings stating a R/S. lol Careful making statements like that as if they are fact when they are just your own speculation.

Hearing rumors that Frank is back in the country and has been a very busy man. Hearing he has been in meetings all week and is finalizing more deals in the US and abroad.


Fingers crossed.




Now the .0001s just got wiped out and it's .0001/2 with 46 mill on the bid.


Something is up.

http://blog.norml.org/2017/02/28/federal-legislation-introduced-to-exclude-cannabis-from-the-controlled-substances-act/?utm

So, reading between the lines in today's PR. Reading into the PR, catching some key words and seeing Dr Raf's qualifications and knowing what I know from previous PR's sounds like the company is piggy backing off a generic drug and enhancing it with the CBD blend. Piggy backing off an existing generic cancer drug will take 12 months for approval instead of 3-10 years.

The company will have a patented cancer treatment Drug. And, well, do we know what the valuation is on a patented cancer treatment that has been proven to work? Well, it's in the BILLIONS of dollar range.

Seriously, this news needs to be understood and looked into. This drug being developed ALONE. Is potentially worth billions of dollars to the market cap. All bets are off on the PPS when this drug hits the market. We thought it'd run like AXIM did but, I truly think that is small potatoes when you throw in a patented Cancer drug worth billions.

Pretty freakin huge.

$ETST Dr Moutih Rafei has done heavy research in immunotherapy, cancer research, TCell and Stem Cell at McGill university. Looks like the company is going to enhance and improve existing generic drugs (based off his expertise in guessing a cancer drug) using their patented blend CBD and patent the cancer drug. Enhancing and already existing drug takes less than 1 year for approval process as clinical trials were done previously. A patented and approved cancer drug will be work 100s of millions if not BILLIONS http://finance.yahoo.com/news/earth-science-tech-inc-cannabis-130000988.html

That's bringing a TON of eyes to $ETST tomorrow!

Slow and steady wins the race. I like that it's climbing up slowly and churning. It really does help to build a new base.

The fast-growing cannabis market is expected to create more jobs in the United States. According to the 2017 Legal Marijuana Outlook, published by New Frontier Data, the cannabis industry is expected to create 283,422 jobs by 2020, with an implied growth rate of more than 17 percent compounded over the next four years

Beautiful set up

Love this morning's PR. Anyone else thinking FDA approval will be HUGE?

$etst news out
http://www.nasdaq.com/press-release/earth-science-tech-initiates-its-cannabis-cannabinoidbased-composition-of-its-2-new-pharmaceutical-20170223-00412

$etst news out
http://www.nasdaq.com/press-release/earth-science-tech-initiates-its-cannabis-cannabinoidbased-composition-of-its-2-new-pharmaceutical-20170223-00412

$etst news out
http://www.nasdaq.com/press-release/earth-science-tech-initiates-its-cannabis-cannabinoidbased-composition-of-its-2-new-pharmaceutical-20170223-00412

Agreed, I think we may not have much time before we see new developments.

Interesting that the most recent scientific advisory board is mostly from Canada. The labs and the CEO are in Canada.

Canada is the leader in CBD and MMJ.


Just thinking of the potential and possibilities here is all.

Good morning everyone. Looks like L2 is shaping up nicely so far this morning.

They just PR'd it today. And 420investor is promoting it so I'll pass. Maybe it will run and I hope it runs hard for you bro. I don't wish for any company to do bad. I hope it runs!

But, since I'm here and posting, I will go and read the site.

Do you have anything specific you can link me to that I should read?